Evidence map›Paper›PMID 32182428›Full record

ArticleBiochemistry2020

Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.

Natasha A Moussouras, Gertrud M Hjortø, Francis C Peterson, Martyna Szpakowska, Andy Chevigné, Mette M Rosenkilde, Brian F Volkman, Michael B Dwinell

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Physiology of chemokines in the cancer microenvironment.American journal of physiology. Cell physiology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Natasha A MoussourasFrom the Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
Gertrud M HjortøDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
Francis C PetersonDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
Martyna SzpakowskaDepartment of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette L-4354, Luxembourg.
Andy ChevignéDepartment of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette L-4354, Luxembourg.
Mette M RosenkildeDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.ORCID 0000-0001-9600-3254
Brian F VolkmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.ORCID 0000-0002-6681-5179
Michael B DwinellFrom the Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.ORCID 0000-0001-5372-633X
Medical College of Wisconsin · USLuxembourg Institute of Health · LUUniversity of Copenhagen · DK

Funding

Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Structural Basis for Chemokine FunctionR01AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2004 to 2019
$4.1M
Sulfotyrosine-guided discovery of small molecule chemokine inhibitorsR01GM097381 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2011 to 2021
$2.9M
Structural Basis for Chemokine FunctionR37AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI Brian F Volkman · 2020 to 2026
$2.8M
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasisU01CA178960 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI DWINELL, MICHAEL B, KALYANARAMAN, BALARAMAN · 2014 to 2018
$2.6M
Biased chemokine receptor signaling in cancer progressionR01CA226279 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI DWINELL, MICHAEL B · 2019 to 2023
$1.9M
Mechanism behind CCL21/CCR7-mediated pancreatic cancer progressionF30CA210587 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI MOUSSOURAS, NATASHA A · 2016 to 2020
$231k
NCI NIH HHS F30 CA210587NCI NIH HHS R01 CA226279NCI NIH HHS U01 CA178960NIAID NIH HHS R01 AI058072NIAID NIH HHS R37 AI058072NIGMS NIH HHS R01 GM097381NIGMS NIH HHS T32 GM080202
6 · The paper itself

Abstract

The chemokines CCL21 and CCL19, through binding of their cognate receptor CCR7, orchestrate lymph node homing of dendritic cells and naïve T cells. CCL21 differs from CCL19 via an unstructured 32 residue C-terminal domain. Previously described roles for the CCL21 C-terminus include GAG-binding, spatial localization to lymphatic vessels, and autoinhibitory modulation of CCR7-mediated chemotaxis. While truncation of the C-terminal tail induced chemical shift changes in the folded chemokine domain, the structural basis for its influence on CCL21 function remains largely unexplored. CCL21 concentration-dependent NMR chemical shifts revealed weak, nonphysiological self-association that mimics the truncation of the C-terminal tail. We generated a series of C-terminal truncation variants to dissect the C-terminus influence on CCL21 structure and receptor activation. Using NMR spectroscopy, we found that CCL21 residues 80-90 mediate contacts with the chemokine domain. In cell-based assays for CCR7 and ACKR4 activation, we also found that residues 92-100 reduced CCL21 potency in calcium flux, cAMP inhibition, and β-arrestin recruitment. Taken together, these structure-function studies support a model wherein intramolecular interactions with specific residues of the flexible C-terminus stabilize a less active monomer conformation of the CCL21. We speculate that the autoinhibitory intramolecular contacts between the C-terminal tail and chemokine body are disrupted by GAG binding and/or interactions with the CCR7 receptor to ensure optimal functionality.

Indexed as

Amino Acid MotifsCalciumChemokine CCL21Dendritic CellsHumansProtein BindingReceptors, CCRReceptors, CCR7ACKR4 protein, humanCalciumCCL21 protein, humanChemokine CCL21Receptors, CCRReceptors, CCR7

Identifiers

PMID32182428
PMCPMC7307649
OpenAlexW3012311885

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.